Aliaa Abdelrahman
Bonn, NW 53121, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Selective, Non-nucleotidic Radiotracer for P2Y12 Receptors: Design, Synthesis, Characterization, and Imaging of Brain Slices.
Journal: Journal of medicinal chemistry
Published: May 14, 2025
Species Differences of P2X4 Receptor Modulators.
Journal: ACS pharmacology & translational science
Published: November 26, 2024
Discovery of an allosteric binding site for anthraquinones at the human P2X4 receptor.
Journal: Nature communications
Published: November 22, 2024
Lipopolysaccharide-Neutralizing Peptide Modulates P2X7 Receptor-Mediated Interleukin-1β Release.
Journal: ACS pharmacology & translational science
Published: August 16, 2024
Preparation and preliminary evaluation of a tritium-labeled allosteric P2X4 receptor antagonist.
Journal: Purinergic signalling
Published: January 24, 2024
Extracellular binding sites of positive and negative allosteric P2X4 receptor modulators.
Journal: Life sciences
Published: August 02, 2022
Discovery and Structure Relationships of Salicylanilide Derivatives as Potent, Non-acidic P2X1 Receptor Antagonists.
Journal: Journal of medicinal chemistry
Published: April 30, 2020
Design, Synthesis and Biological Evaluation of Highly Potent Simplified Archazolids.
Journal: ChemMedChem
Published: March 10, 2020
2-Substituted α,β-Methylene-ADP Derivatives: Potent Competitive Ecto-5'-nucleotidase (CD73) Inhibitors with Variable Binding Modes.
Journal: Journal of medicinal chemistry
Published: February 12, 2020
Synthesis of Novel Potent Archazolids: Pharmacology of an Emerging Class of Anticancer Drugs.
Journal: Journal of medicinal chemistry
Published: January 29, 2020
Thermal proteome profiling identifies the membrane-bound purinergic receptor P2X4 as a target of the autophagy inhibitor indophagolin.
Journal: Cell chemical biology
Published: October 10, 2019
Last Updated: 09/26/2026